Immunotherapy and evolving approaches for basal cell carcinoma

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA Prof. Ketty Peris, Catholic University of Rome, Rome, Italy This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME.